Resection for pancreatic cancer with arterial involvement: A paradigm shift away from unresectable to “how to do it”

Published:November 27, 2020DOI:
      During the past 30 years, pancreatic surgery has evolved considerably. Honestly, I would not have anticipated many of these changes, but luckily enough, they have occurred and have improved the management and the prognosis of patients with pancreatic cancer. Some of these changes have been truly groundbreaking, such as the advent of minimally invasive distal and now even proximal pancreatectomies, the availability of effective medical therapies, and the improved definition of prognostic factors. In keeping with some of these changes, some centers have begun to extend their indications for pancreatic resections to arterial involvement. The value of these extended procedures, however, remains controversial.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Miao Y.
        • Jiang K.
        • Cai B.
        • et al.
        Arterial divestment instead of resection for locally advanced pancreatic cancer (LAPC).
        Pancreatology. 2016; 16: S59